1 March 2024
For our second year of Translation conference has a powerful programme of speakers. Gathering on 18th-19th April in London, we're bringing together the dementia research community to focus on translational developments which are taking discoveries through in-human research to biomarkers, trials and into therapeutics.
12 February 2024
The BBC's Panorama reports that there are challenges for the NHS in offering new dementia drugs Lecanemab and Donanemab. Accurate diagnosis is vital to determine who can benefit most from these Alzheimer's drugs. Two DPUK studies are assessing the feasibility of reliable diagnoses.
12 February 2024
A new DPUK study of blood samples will look at genetic and environmental factors that influence immune system signatures.
18 January 2024
It is time to register for Translation 2024 - or risk missing out on our EARLYBIRD discount. The conference programme for Translation 2024 is almost complete and soon we will be revealing the full programme and list of speakers. Watch this space for more very soon.
The DPUK Data Portal gives researchers rapid, secure access to millions of health research records.
Our Trials Delivery Framework matches public volunteers to the right dementia studies.
Our Experimental Medicine Incubator accelerates and de-risks the development of new treatments.
A project led by researchers at Cardiff University is analysing data in the DPUK Data Portal to predict genetic risk of dementia, focusing on genes related to the brain's immune system.
Jodi Watt - Research Assistant
Jodi is a Post-Doctoral Research Assistant at the University of Glasgow. She works as part of a DPUK2 project that aims to identify possible targets for drug repurposing in dementia, using drug-wide association study methodology.
Jodi holds a PhD in Radiological Sciences from the University of Nottingham. Outside of her research work, she is very interested in Equity, Diversity and Inclusion issues in academia and practice.